SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028411
Filing Date
2021-05-17
Accepted
2021-05-17 16:25:08
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-10q_20210331.htm 10-Q 2085469
2 EX-31.1 alxo-ex311_7.htm EX-31.1 21290
3 EX-31.2 alxo-ex312_9.htm EX-31.2 21258
4 EX-32.1 alxo-ex321_6.htm EX-32.1 9456
5 EX-32.2 alxo-ex322_8.htm EX-32.2 9429
  Complete submission text file 0001564590-21-028411.txt   5455190

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxo-20210331.xml EX-101.INS 824266
7 XBRL TAXONOMY EXTENSION SCHEMA alxo-20210331.xsd EX-101.SCH 46276
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxo-20210331_cal.xml EX-101.CAL 44983
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20210331_def.xml EX-101.DEF 112229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20210331_lab.xml EX-101.LAB 343791
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20210331_pre.xml EX-101.PRE 244254
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 21931170
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences